Min Huang

8PUBLICATIONS
27CO-AUTHORS
Pharmaceutical delivery technologiesMolecular targetsChemotherapyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 23, 2026
Hsc70-Mediated Targeting Chimeras for Targeted Protein Degradation via Chaperone-Mediated Autophagy.

|Aug 04, 2024
A region-confined PROTAC nanoplatform for spatiotemporally tunable protein degradation and enhanced cancer therapy.

Jing Gao, Xingyu Jiang, Shumin Lei

|Mar 19, 2024
Oncogenic KRAS Induces Arginine Auxotrophy and Confers a Therapeutic Vulnerability to SLC7A1 Inhibition in Non-Small Cell Lung Cancer.

Xiameng Gai, Yingluo Liu, Xiaojing Lan

|Jan 08, 2024
Low-Dose Chemotherapy Preferentially Shapes the Ileal Microbiome and Augments the Response to Immune Checkpoint Blockade by Activating AIM2 Inflammasome in Ileal Epithelial Cells.

Congying Pu, Yize Li, Yixian Fu

|Apr 23, 2022
SLC1A1-mediated cellular and mitochondrial influx of R-2-hydroxyglutarate in vascular endothelial cells promotes tumor angiogenesis in IDH1-mutant solid tumors.

Xiaomin Wang, Ziqi Chen, Jun Xu

|Mar 29, 2022
Metabolic Regulation of CD8+ T Cells: From Mechanism to Therapy.

Ying Zheng, Xiaomin Wang, Min Huang

Pageof 2

Frequent Collaborators

2 joint publications

Shu-Hai Lin

1 joint publications

Zuoquan Xie

1 joint publications

Minjia Tan

1 joint publications

Jia Liu